Sodium–glucose cotransporter 2 inhibitors and inverse risk of new-onset atopic dermatitis in a cohort with diabetes: a nationwide active-comparator study
SGLT2i show a significant protective effect against AD in patients with diabetes compared with DPP4i. This robust finding, consistent across weighting and sensitivity analyses, supports SGLT2i use, with a strong protective effect also found in the dose-response analysis.
Authors
- Yi‐Hsien Chen (ORCID: https://orcid.org/0000-0002-7019-2357)
- Sheng-Yin To (ORCID: https://orcid.org/0009-0007-5996-2879)
- Li‐Ting Kao (ORCID: https://orcid.org/0000-0003-0692-7408)
- Hui‐Han Kao
- Yuan-Liang Wen
- Chun‐Cheng Liao (ORCID: https://orcid.org/0000-0002-7508-6297)
- Wan‐Ting Hsu (ORCID: https://orcid.org/0000-0002-6677-0951)
- Huiwen Yang (ORCID: https://orcid.org/0009-0003-5768-8424)
Institutions
- Tri-Service General Hospital (TW)
- National Taiwan University (TW)
- Taichung Armed Forces General Hospital (TW)
- National Defense Medical Center (TW)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1093/bjd/ljaf086
- Citations
- 1
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.00